Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Common Stock Issued

Cash raised by issuing new shares.

Atrium Therapeutics, Inc.NASDAQ: RNA

Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026

Common stock issued of $0 in Q1 FY2026

Q1 FY2026 common stock issued was $0.

Context

  • Common stock issued amounted to 0.0% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Common Stock Issued vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Common Stock Issued figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.